Lobe Sciences Ltd. (LOBEF)
Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD). Additionally, they engineer specialized devices aimed at enhancing the efficiency of drug administration. This organization, headquartered in Vancouver, Canada, underwent a name change from Greenstar Biosciences Corp. to Lobe Sciences Ltd. in November 2020.
Sector: Biotechnology
Industry: Biotechnology
Lobe Sciences Ltd.
OTC:LOBEFHealthcare · Biotechnology
+10.81%$0.0355
CLOSEDPrev close$0.0320+10.81%Close$0.0355
Mkt Cap$10.93M
EV-
Float83.08M
O/S308.18M
VOL933 sh
$ Vol$33
RVOL0.01×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
MCap$10.93MFloat83.08MO/S308.18M
Dilution